|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-36S1
|
$125,000
|
$2,500
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-36
|
$2,600,006
|
$52,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-02
|
$551,500
|
$27,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Partici
|
3U10CA180864-01S1
|
$70,000
|
$2,625
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Partici
|
5U10CA180864-02
|
$620,949
|
$23,286
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
VHL tumor suppressor gene and the initiation of renal cell carcinoma
|
5R01CA109860-11
|
$328,499
|
$328,499
|
HSU, TIEN
|
BOSTON MEDICAL CENTER
|
|
Veterans Administration hospitalization database, Patient Treatment File, and Ou
|
ZIA CP010126 - 00580
|
$39,863
|
$3,986
|
McGlynn, Katherine
|
DCEG (NCI)
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-02
|
$528,806
|
$26,440
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-02
|
$700,000
|
$17,500
|
SCHILLER, JOAN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
3U10CA180858-02S1
|
$100,000
|
$2,500
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-02
|
$1,192,600
|
$29,815
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Urologic Oncology Research Training Grant
|
2T32CA082088-16
|
$246,134
|
$36,920
|
CARVER, BRETT
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Urologic Oncology Branch Consult Core
|
ZID BC 011092
|
$1,805,205
|
$1,083,123
|
Linehan, W. Marston
|
CCR (NCI)
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-27S1
|
$198,450
|
$1,985
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-27
|
$6,097,616
|
$60,976
|
LAWRENCE, THEODORE
|
UNIVERSITY OF MICHIGAN
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S1
|
$395,573
|
$3,956
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S2
|
$124,964
|
$1,250
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S3
|
$68,339
|
$683
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
3P30CA134274-08S4
|
$200,000
|
$2,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Maryland Greenebaum Cancer Center Support Grant
|
5P30CA134274-08
|
$1,535,000
|
$15,350
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-16S1
|
$114,745
|
$1,147
|
HEDGES, JERRIS
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
3P30CA071789-16S3
|
$177,700
|
$1,777
|
HEDGES, JERRIS
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Hawaii Cancer Center CCSG
|
5P30CA071789-16
|
$1,361,692
|
$13,617
|
HEDGES, JERRIS
|
UNIVERSITY OF HAWAII AT MANOA
|
|
University of Colorado NTCN Lead Academic Participating Site (LAPS)
|
5U10CA180834-02
|
$692,055
|
$34,603
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Understanding T Cell Rapamycin Resistance
|
ZIA BC 011220
|
$263,739
|
$52,748
|
Fowler, Daniel
|
CCR (NCI)
|
|
UM LAPs- U10 Grant
|
5U10CA180801-02
|
$684,929
|
$34,246
|
ZALUPSKI, MARK
|
UNIVERSITY OF MICHIGAN
|
|
UCDCCC NCTN U10 Program
|
3U10CA180846-02S1
|
$99,708
|
$2,493
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-02
|
$630,226
|
$15,756
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
TWO HIT GENE MAPPING IN RENAL CELL CARCINOMA
|
5R21CA175979-02
|
$147,782
|
$147,782
|
MCKAY, JAMES
|
INTERNATIONAL AGENCY FOR RES ON CANCER
|
|
Tumor suppressive functions of the urea cycle in renal cell carcinoma
|
1F32CA192758-01
|
$54,194
|
$54,194
|
OCHOCKI, JOSHUA
|
UNIVERSITY OF PENNSYLVANIA
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$376,957
|
$7,539
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Translational Surgical Pathology
|
ZIE SC 000853
|
$171,153
|
$68,461
|
Merino, Maria
|
CCR (NCI)
|
|
Translational Research in Cancer
|
5P30CA056036-16
|
$2,807,751
|
$56,155
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
Tissue Processing/Sequencing Facility
|
ZIC BC 011044
|
$470,155
|
$235,078
|
Vocke, Cathy
|
CCR (NCI)
|
|
The von Hippel-Lindau Tumor Suppressor Protein:Roles in Cancer and Oxygen Sensing
|
5R01CA068490-20
|
$292,284
|
$292,284
|
KAELIN, WILLIAM
|
DANA-FARBER CANCER INST
|
|
The Therapeutic Potential of Targeting MYC Activity in Renal Tumorigenesis
|
1R21CA194987-01
|
$196,011
|
$196,011
|
LEUNG, YEE MAN JANET
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
The targeting of the HIF switch in kidney cancer
|
5R01CA181106-02
|
$521,079
|
$521,079
|
KOH, MEI YEE
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
THE ROLE OF LIN28B IN WILMS TUMOR
|
5F31CA186444-02
|
$35,440
|
$35,440
|
YERMALOVICH, ALENA
|
CHILDREN'S HOSPITAL CORPORATION
|
|
The Role of IKK and NF-kappaB in Controlling mTOR Signaling and TSC Progression
|
5R00CA149178-05
|
$238,663
|
$59,666
|
DAN, HANCAI
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
The Role of Fgf Signaling in Vertebrate Development
|
ZIA BC 010338
|
$234,356
|
$46,871
|
Lewandoski, Mark
|
CCR (NCI)
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-21S1
|
$79,482
|
$795
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-21
|
$4,814,560
|
$48,146
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
The Impact of Mitochondrial Repression and Lipid Accumulation by HIF on Tumor Gro
|
1R35CA197713-01
|
$782,337
|
$782,337
|
GIACCIA, AMATO
|
STANFORD UNIVERSITY
|
|
The function of Snf5, an epigenetic tumor suppressor
|
2R01CA113794-11
|
$369,063
|
$369,063
|
ROBERTS, CHARLES
|
DANA-FARBER CANCER INST
|
|
The effect of cancer-associated SETD2 mutations on transcription and chromatin or
|
1F30CA192643-01
|
$33,479
|
$33,479
|
FAHEY, CATHERINE
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
The addition of fish oil to sorafenib may prevent kidney cancer metastasis
|
5R03CA181837-02
|
$78,000
|
$78,000
|
WEISS, ROBERT
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Targeting Genetic and Metabolic Alterations in Distinct Subtypes of RCC
|
ZIA BC 011648
|
$353,098
|
$353,098
|
Srinivasan, Ramaprasad
|
CCR (NCI)
|
|
SWOG Statistics and Data Management Center
|
5U10CA180819-02
|
$6,686,248
|
$133,725
|
LEBLANC, MICHAEL
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
SWOG Network Group Operations Center of the NCTN
|
3U10CA180888-02S2
|
$34,899
|
$698
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
SWOG Network Group Operations Center of the NCTN
|
5U10CA180888-02
|
$10,609,226
|
$212,185
|
BLANKE, CHARLES
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
Total relevant funding to Kidney Disease for this search: $42,998,519
|